[Differentiated thyroid cancers].
The Authors, after a review of the topic of thyroid cancer, focus on the epidemiology, aetiology and diagnosis of well-differentiated thyroid cancers. They then describe their own case series and their many years' experience in treating the patients affected by this pathology, which is generally regarded as having low malignancy. Nowadays the Authors consider the treatment of choice the total thyroidectomy with central compartment lymphectomy, eventually associated with metabolic radiotherapy.
Gorgone
S
S
Università degli Studi di Messina, Facoltà di Medicina e Chirurgia, Cattedra di Chirurgia Generale.
Campennì
A
A
Calbo
E
E
Catalfamo
A
A
Sciglitano
P
P
Sofia
L
L
Niceta
M
M
Borzì
R
R
Calbo
L
L
D018263:Adenocarcinoma, Follicular / Q000453:epidemiology* / Q000532:radiotherapy / Q000556:secondary / Q000601:surgery; D018249:Adenoma, Oxyphilic / Q000453:epidemiology / Q000532:radiotherapy / Q000556:secondary / Q000601:surgery; D002291:Carcinoma, Papillary / Q000453:epidemiology* / Q000532:radiotherapy / Q000556:secondary / Q000601:surgery; D002454:Cell Differentiation; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D007558:Italy / Q000453:epidemiology; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D011379:Prognosis; D012189:Retrospective Studies; D013964:Thyroid Neoplasms / Q000453:epidemiology* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D013965:Thyroidectomy; D013974:Thyroxine / Q000627:therapeutic use
D007457:Iodine Radioisotopes; D013974:Thyroxine